5 Best Long Term Low Risk Stocks to Buy According to Hedge Funds

In this article, we will take a look at the 5 Best Long Term Low Risk Stocks to Buy According to Hedge Funds. For deeper discussion and analysis, read 10 Best Long Term Low Risk Stocks to Buy According to Hedge Funds.

A technical stock market chart. Photo by Energepic from Pexels

5. Gilead Sciences, Inc. (NASDAQ:GILD)

Number of Hedge Fund Holders: 71

5-Year Return: 88.61%

Beta Value: 0.33

On May 10, Morgan Stanley lowered its price recommendation on Gilead Sciences, Inc. (NASDAQ:GILD) to $168 from $175. It reiterated an Overweight rating on the shares. The firm updated its model for the company following the first-quarter earnings report.

On May 8, Truist lifted its price goal on GILD to $157 from $155. It kept a Buy rating on the stock. The analyst said the company delivered first-quarter revenue and earnings results above expectations and also raised its FY26 revenue guidance. According to the research note, the performance was driven by strength in the HIV business, especially Yeztugo. The firm also highlighted management’s comments around early persistence signals. It noted that Yeztugo showed the highest persistence among patients receiving re-treatment in the PrEP setting. Truist described those trends as encouraging and said they remain central to its view that Yeztugo can achieve durable growth toward a potential $7B-plus peak revenue opportunity.

Gilead Sciences, Inc. (NASDAQ:GILD) is a biopharmaceutical company focused on developing medicines to prevent and treat life-threatening diseases. Its areas of focus include HIV, viral hepatitis, COVID-19, cancer, and inflammation.